10 Parkinsons Disease Clinical Trials in Palo Alto, CA (2026)

Q: How do I join a clinical trial in Palo Alto?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you.

Recruiting Parkinsons Disease Studies in Palo Alto

NCT06878261Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive...

Palo Alto, CAPHASE3990 participantsAstraZeneca

View Study Details

NCT07174310Recruiting

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of prasinezumab compared with placebo in participants with early-stage Parkinson's disease (PD) on stable sympt...

Palo Alto, CAPHASE3900 participantsHoffmann-La Roche

View Study Details

NCT07417111Recruiting

Continued Pressure for Alveolar Protection (CPAP Trial)

The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopu...

Palo Alto, CANA860 participantsNICHD Neonatal Research Network

View Study Details

NCT04373317Recruiting

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients also have other sympt...

Palo Alto, CAPHASE4358 participantsVA Office of Research and Development

View Study Details

NCT06765668Recruiting

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

The primary purpose of this study is to evaluate efficacy and safety of CREXONT under real world conditions in participants with Parkinson disease (PD)....

Palo Alto, CAPHASE4220 participantsImpax Laboratories, LLC

View Study Details

NCT06680830Recruiting

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the ...

Palo Alto, CAPHASE2150 participantsNeuron23 Inc.

View Study Details

NCT07432958Recruiting

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

This is a Phase 2 study in people with Parkinson's disease who experience motor fluctuations while taking levodopa. The study will evaluate how effective two different doses of the study drug AP-472 a...

Palo Alto, CAPHASE2150 participantsAppello Pharmaceuticals, Inc.

View Study Details

NCT07219927Recruiting

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Real-World Participants Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: A Prospective, Phase 4, Multicenter, Observational Study in Parkinson's Disease...

Palo Alto, CA120 participantsSupernus Pharmaceuticals, Inc.

View Study Details

NCT06944522Recruiting

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease...

Palo Alto, CAPHASE3102 participantsBlueRock Therapeutics

View Study Details

NCT07354477Recruiting

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG...

Palo Alto, CAPHASE214 participantsQlaris Bio, Inc.

View Study Details

About Parkinsons Disease Clinical Trials in Palo Alto

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 10 parkinsons disease clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 3,864 participants. Research is being sponsored by AstraZeneca, Hoffmann-La Roche, NICHD Neonatal Research Network and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Palo Alto — FAQ

Are there parkinsons disease clinical trials in Palo Alto?

Yes, there are 10 parkinsons disease clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 10 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 19, 2026 from ClinicalTrials.gov